<p>A pioneering treatment has shown extraordinary potential for treating <strong>spina bifida in the womb</strong>, offering new hope to families affected by this serious birth defect. The results, published in the prestigious <em>Lancet</em> medical journal, represent what scientists are calling a "major step toward a new kind of fetal therapy."</p>
<h2>How It Works</h2>
<p>Spina bifida is a condition in which a baby's spinal cord is not properly enclosed during gestation, potentially leading to a range of lifelong disabilities including mobility challenges. The new treatment involves applying <strong>stem cells harvested from the mother's own placenta</strong> to the baby's spine while surgeons simultaneously repair it in the womb.</p>
<p>The approach was developed by researchers at the <strong>University of California Davis Department of Surgery</strong>, led by Diana Farmer, chair of the department, who said the procedure "paves the way for new treatment options for children with birth defects."</p>
<h2>Real Families, Real Results</h2>
<p>Six mothers took part in the phase one trial. Among them was <strong>Michelle Johnson</strong>, whose son Tobi was born in 2022 after receiving the in-utero treatment.</p>
<p>"Our family couldn't feel more blessed," said Johnson. "Tobi's physical and mental abilities are nothing short of a miracle."</p>
<p>The trial showed that the stem cell treatment <strong>improved children's mobility and quality of life</strong> beyond what conventional fetal surgery alone could achieve.</p>
<h2>What's Next</h2>
<p>Co-inventor of the treatment Aijun Wang described it as a "major step toward a new kind of fetal therapy," while UK-based spina bifida charity Shine called the results "very exciting."</p>
<p>While further research and larger trials are needed, the implications are profound. The ability to use a mother's own cells to heal her baby before birth represents a fundamental shift in how we approach congenital conditions — treating them before they can cause lasting damage.</p>
<p><em>Sources: The Lancet, University of California Davis, Positive News, Shine charity</em></p>
